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1682-606X/Copyright ª 2014, TaiwanSummary Objective: The efficacy of surgical treatments on supratentorial intracerebral
hemorrhage (STICH) is not conclusive although many studies have been performed. Relevant
factors, such as the injury inflicted to the brain by different kinds of surgery, degrees of
severity, and locations of intracerebral hemorrhage (ICH), should be taken into consideration
for a better appraisal of the efficacy of surgery on STICH.
Methods: Randomized controlled trials to evaluate the efficacy of surgery on STICH were
included for this meta-analysis. The appraised primary outcome was death, and the secondary
outcome was death or dependence.
Results: Eighteen studies with 3616 patients were included in this meta-analysis. Surgery and
minimal invasive surgery (MIS) showed a significant reduction in mortality as the primary
outcome, and mortality or dependence as the secondary outcome, for all the intracerebral
hemorrhage (ICH) patients and of the subgroup of deep-located ICH patients. MIS also showed
a significant reduction both in mortality and dependence of the subgroup of putaminal ICH pa-
tients. In contrast, craniotomy showed no significantly better outcome than medical treat-
ment. However, we found the mortality rate of the medical treatment group in the studies
of craniotomy and MIS was different: 39% versus 20% for all cases of ICH, 50% versus 16% for
putaminal ICH, and 51% versus 15% for deep ICH.have no conflicts of interest regarding this research.
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Supratentorial intracerebral hemorrhage 91Conclusion: In terms of mortality and dependence, MIS had significantly better results than
medical treatment for STICH, deep ICH, and putaminal ICH. In the present review, craniotomy
showed no significantly better outcome than medical treatment.
Copyright ª 2014, Taiwan Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Many studies conducting meta-analyses 1e5 on randomized
controlled trials to evaluate the efficacy of surgical treat-
ments for supratentorial intracerebral hemorrhage (STICH)
have shown diverse results. However, many factors that are
relevant to the treatment outcomes in these studies, such
as degrees of the severity, intracerebral hemorrhage (ICH)
location, types of surgery, the definition of dependence in
the study method, and the management of the cases lost to
follow-up, were different in these studies. Because the
treatment of STICH is still controversial, the review pro-
cedure should be more carefully designed, and an
evidence-based methodology is necessary.
To date, various studies and guidelines 6e8 for managing
ICH are still not conclusive about the effects of surgery on
STICH. One potential factor is the additional injury inflicted
by surgery to the brain. For example, the additional injury
of surgery for putaminal ICH would be different from that
for lobar ICH, and so the injury of craniotomy would be
different from that of the minimal invasive surgery (MIS,
including stereotactic aspiration of ICH or endoscopic
evacuation of ICH). Therefore, instead of comparing the
results by pooling together all types of surgery against
those of conservative medical treatment, different surgical
methods should be viewed as independent factors for
comparison. In addition, the results of putaminal ICH and
deep-located ICH should be reviewed separately. By doing
so, effects of different modes of surgery in these random-
ized studies can be delineated.
2. Methods
We followed the PRISMA statement 9 to identify relevant
studies, and two review authors independently identified
the articles according to inclusion and exclusion criteria.
Studies published in PubMed (1966e2012), Medline
(1966e2012), and the Cochrane library regarding CT-
confirmed STICH were included. The types of intervention
included surgery (craniotomy, endoscopic evacuation or
stereotactic aspiration) supplemented with medical treat-
ment, and medical treatment alone. Exclusion criteria
were hemorrhage caused by brain injury, brain tumor
bleeding, intracranial aneurysm, or arteriovenous malfor-
mation rupture. Papers that were irrelevant to the surgical
results of ICH were excluded, and so were all retrospective
reviews. We did not include the reports that only compared
the results of different types of surgery without a control
medical treatment group.
The locations of STICH were differentiated into puta-
minal and deep-located ICH, if mentioned. In the present
study, the primary outcome was death, and the secondaryoutcome was death or dependence. For assessment of
“dependence”, the definition of the primary outcome from
the original studies was adopted. Comparisons were drawn
on groups of surgery for STICH versus medical treatment,
craniotomy for STICH versus medical treatment, MIS for
STICH versus medical treatment, surgery for deep ICH
versus medical treatment, craniotomy for deep ICH versus
medical treatment, MIS for deep ICH versus medical
treatment, surgery for putaminal ICH versus medical
treatment, craniotomy for putaminal ICH versus medical
treatment, and MIS for putaminal ICH versus medical
treatment. The data were also calculated separately with
and without the cases lost to follow-up.
Pooled estimates of the effects of surgery on STICH were
acquired by the ManteleHaenszel method. The 95% confi-
dence interval (CI) of the results, and the odds ratio (OR)
for surgical effects, were calculated by the dichotomous
variables. The random-effects model was used for the
possibility of heterogeneity across studies. We assessed
heterogeneity among the trial results using the chi-square
test and I square index (I2). A p value of 0.05 or less was
taken as statistically significant and I2 values of 25%, 50%,
and 75% were considered as low, moderate, and high het-
erogeneity, respectively. Because the severity in the
studies of MIS may be different from that of craniotomy,
the experimental event rate (EER, surgical treatment
group), control event rate (CER, medical treatment group),
absolute risk reduction (ARR) and the number needed to
treat to benefit (NNTB) were calculated to evaluate if there
were any differences between these two groups.
3. Results
The 3678 studies from PubMed (1966e2012), and 3890
studies from Ovid Medline (1966e2012) on spontaneous
STICH were retrieved, including 125 randomized studies
and meta-analyses. The original studies from references of
meta-analyses were also reviewed, and several additional
papers were included. In the end, 18 studies10e27 with 3616
patients were included for this meta-analysis (Fig. 1). All
these studies had data of mortality about surgery and
medical treatment, and 17 of them also had also data
regarding dependence. Criteria for evaluating “depen-
dence” included Auer’s Grade 5 (totally dependent on
others for activities of the day), Batjer’s Level 1 (dead or
vegetative) and Level 2 (dependent at home or institution),
extended Glasgow Outcome Scale22, 3 on the 5-point
Glasgow Outcome Scale11,15,16,23, 3 on the modified
Rankin Scale score19,21,24e27, and 60 of the Barthel
Index14,24 (Table 1).
The reported duration of follow up was 30 days in one
study, 3 months in four studies, 6 months in 10 studies and 1
3678 publications from PubMed
Excluded criteria: 
1. Irrelevant to the surgical results.
2. Retrospective studies.
125 randomized studies and 
meta-analyses were fully reviewed
18 eligible studies
Excluded studies: 
1. No medical treatment group as control.
2. No clear data of surgical results.
3. Duplicated studies.
Additional studies: 
Eligible original randomized studies from 
reference of qualified meta-analyses.
3890 publications from Ovid Medline
Figure 1 Flow charts of all studies included.
Table 1 All included studies for meta-analysis.
Case number
(surgery versus medical)
Follow-up duration Primary outcome and
definition of dependence
Auer 1989 (E) 100 (50 vs 50) 6 months Grade 51
Juvela 1989(C) 53 (26 vs 27a) 6 months GOS 3
Batjer 1990 (C) 17b (8 vs 9) 6 months Level 1 and 22
Chenc1992 (C or S) 127 (64 vs 63) 3 months 中, 差3
Morgenstern 1998 (C) 34 (17 vs 17) 6 months BI 60
Zuccarello 1999 (C or S) 20 (9 vs 11) 3 months GOS 3
Chengc 2001 (S) 500 (266 vs 234) 3 to 6 months4 中, 差4
Kurtsoy 2001 (C) 45 (21 vs 24) 30 days GOS III and GCS IV5
Hosseini 2003 (S) 37 (20 vs 17) 1 year Average Karnofski’s score6
Teernstra 2003 (S) 70 (36 vs 34) 6 months mRS 3
Sun 2004 (C or S) 124 (34 vs 90) 6 months Dependent7
Hattori 2004 (S) 242 (121 vs 121) 1 year mRS 3
Mendelow 2005 (C, E or S) 982 (477 vs 505) 6 months Extended GOS8
Pantazis 2006 (C) 108 (54 vs 54) 1 year GOS 3
Wang 2008 (C, E, or S) 389d (216 vs 173) 6 months mRS >3 or BI <60
Miller 2008 (E) 10 (6 vs 4) 3 months mRS 3
Wang 2009 (S) 377 (195 vs 182) 3 months mRS 3
Kim 2009 (S) 387 (204 vs 183) 6 months mRS 3
E Z endoscopic surgery; C Z craniotomy; S Z stereotactic surgery.
1 Grade 5: conscious patients totally dependent on others for activities of the day.
2 Level 1: dead or vegetative; level 2: dependent at home or institution.
3 中,差: no definition in papers.
4 中,差: Barthel Index was used to evaluate the results 3 to 6 months after intervention, without further definition.
5 GOS III: severe disability, same as GOS 3; GOS IV: vegetative state, same as GOS 2.
6 Only average Karnofski’s score were compared between the studied groups.
7 No definition of “dependent”.
8 Extended GOS: favourable and unfavourable outcomes were defined a little different on the basis of the original clinical status at
randomization.
a One patient who had been excluded due to brain tumor found during autopsy was added back to the medical treatment group.
b Four patients assigned to BMM (best medical management) plus ICP (Intracranial pressure) monitoring were excluded due to ven-
triculostomy received.
c Same author used different last name in English; two different studies in different periods and hospitals.
d Only “ultra-early” and “early” groups were included because there were no clear data about dependency in “late” groups.
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Supratentorial intracerebral hemorrhage 93year in three studies. Data on death at the end of follow up
were available for all the 18 studies. At the end of the
follow up, it was found that surgery was associated with a
statistically significant reduction in mortality of all ICH
patients (OR 0.65, 95% CI 0.50 to 0.85, pZ 0.002, Fig. 2A),
and of the subgroup of deep ICH patients (OR 0.60, 95% CI
0.39 to 0.92, p Z 0.02, Fig. 2B). MIS showed significant
reduction in mortality of all ICH patients (OR 0.55, 95% CI
0.35 to 0.87, p Z 0.01, Fig. 3A), of the subgroup of puta-
minal ICH patients (OR 0.52, 95% CI 0.31 to 0.86, pZ 0.01,
Fig. 3B) and of the deep ICH patients (OR 0.57, 95% CI 0.34
to 0.96, p Z 0.04, Fig. 3C).
A total of 17 studies reported the outcome of death or
dependence at the end of follow up. Surgery was associated
with a statistically significant reduction in mortality or
dependence of all the ICH patients (OR 0.62, 95% CIFigure 2 Mortality rate of surgery versus medical treatment. Sig
the subgroup of deep intracranial hemorrhage patients.0.46e0.84, p Z 0.002, Fig. 4A), and of the subgroup of
deep ICH patients (OR 0.6, 95% CI 0.37e0.96, p Z 0.04,
Fig. 4A). MIS was found to be associated with a significant
reduction in mortality or dependence of all the ICH patients
(OR 0.52, 95% CI 0.33e0.80, p Z 0.003, Fig. 5A), of the
subgroup of putaminal ICH patients (OR 0.44, 95% CI
0.32e0.61, p < 0.001, Fig. 5B), and of the deep ICH pa-
tients (OR 0.39, 95% CI 0.30e0.52, p < 0.001, Fig. 5C).
Craniotomy showed no significantly better outcome
than medical treatment in mortality of all the ICH patients
(OR 0.72, 95% CI 0.42e1.22, pZ 0.22), of the subgroup of
putaminal ICH patients (OR 0.9, 95% CI 0.39e2.07,
p Z 0.8) and of the deep ICH patients (OR 0.57, 95% CI
0.23e1.40, p Z 0.22). Craniotomy also showed no signif-
icantly better outcome than medical treatment in mor-
tality or dependence of all the ICH patients (OR 0.83, 95%nificant results were found for (A) all included patients and (B)
Figure 3 Mortality of MIS versus medical treatment. Significant results were obtained for (A) all included patients, (B) the
subgroup of putaminal intracranial hemorrhage (ICH) patients and (C) the deep-ICH patients.
94 C.-D. Yang et al.CI 0.41e1.67, p Z 0.6), of the subgroup of putaminal ICH
patients (OR 0.77, 95% CI 0.18e3.28, pZ 0.73) and of the
deep ICH patients (OR 0.62, 95% CI 0.22e1.78, p Z 0.38,
Table 2).
Upon further inspection, it was found that the event rate
of the medical treatment group was different between the
studies of craniotomy and MIS. The mortality rate of the
medical treatment group in the studies of craniotomy and
MIS was 39% (74/188) and 20% (126/646), respectively.
When the outcome event was death or dependence for
analysis, the event rate of the medical treatment group in
the studies of craniotomy and MIS was 77% (404/524) and
67% (475/713), respectively (Table 2).
For putaminal ICH, MIS was adopted much more than
craniotomy, and thus the sample sizes were quite different
between these two groups (124 cases for craniotomy and665 cases for MIS). When death was taken as the outcome
for comparison between the medical treatment groups in
craniotomy versus MIS studies, it was found that the event
rate was 50% in craniotomy studies (34/68) versus 16% of
MIS studies (52/329). When the outcome was death or
dependence, the event rate for the medical treatment
group in craniotomy studies was 81% (55/68) whereas that
in the MIS studies was 67% (221/328) (Table 2).
For deep ICH, MIS was also adopted much more than
craniotomy, and thus the sample sizes were quite different
between these two groups (172 cases for craniotomy and
1115 cases for MIS). When death was taken as the outcome
for comparison between the medical treatment groups in
craniotomy versus MIS studies, it was found that the event
rate was 51% in craniotomy studies (48/95) versus 15% of
MIS studies (89/582). When the outcome was death or
Figure 4 Mortality or dependence of surgery versus medical treatment. Significant results were obtained for (A) all included
patients, and (B) the subgroup of deep-intracranial hemorrhage patients.
Supratentorial intracerebral hemorrhage 95dependence, the event rate for the medical treatment
group in craniotomy studies was 83% (79/95) whereas that
in MIS studies was 65% (367/564) (Table 2).4. Discussion
Many reported randomized studies and their meta-analyses
showed different results about the effects of surgery on
STICH. The beneficial effects of surgery on STICH included
removing the mass, reducing the toxicity of ICH, and pre-
serving the penumbra area around the ICH.28 However,
surgery itself unavoidably inflicted certain brain damage.
Therefore, the clinical outcome of surgery-treated ICH is
related to the degree of brain damage brought about by the
procedure. For example, less injury caused by operation on
lobar ICH, especially for ICH 1 cm near the brain surface, is
correlated to a better outcome as compared to that for
deep-located ICH, including putaminal ICH. Additionally,the minimal invasive surgery, including the stereotactic
aspiration and endoscopic removal of hematoma, usually
has better clinical results due to less harm to the brain tis-
sue. This is consistent with our finding in the current study
that minimal invasive surgery had better results than med-
ical treatment for all STICH, deep ICH and putaminal ICH.
However, the less favorable results of craniotomy may also
be due to other factors. For example, the lower death rate
in the medical treatment group for MIS studies than that for
craniotomy studies (20% and 39%, respectively as shown in
Table 2) suggests that the overall severity was different from
the beginning. Therefore, various outcomes from different
surgeries may be due to different degrees of injury to brain
by surgical methods (craniotomy versus MIS), different ICH
locations (putaminal or deep-located ICH versus lobar ICH)
as well as the severity of the patients’ conditions.
For meta-analysis of studies, intent-to-treat should be
considered to minimize the bias. Some reports analyzed the
results including the number of cases lost to follow up, but
Figure 5 Mortality or dependence of MIS versus medical treatment. Significant results were obtained for (A) all included pa-
tients, (B) the subgroup of putaminal intracranial hemorrhage (ICH) patients, and (C) the deep-ICH patients.
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had cases lost to follow up 14,17,19,22,26. However, no great
differences were observed when data with or without cases
lost to follow-up were compared.
In the present study, several different data from other
previous reviews were used with careful consideration. We
included one patient in Juvela’s study11 who was assigned to
the medical treatment group initially and was excluded later
due to the brain tumor found at autopsy. Four patients
assigned to the best medical treatment (BMM) plus ICP moni-
toring in Batjer’s study12 were excluded because they under-
went ventriculostomy for drainage. In Wang’s (2008) study 24,
only surgical data in “ultra-early” and “early” stages were
included since no clear data of dependence were reported in
the group of surgery in the “late” stages. Additionally, the
number of deaths or that of dependence cases in Kim’s study27
was derived by subtracting the cases with an modified Rankin
Scale (MRS) score of&2 at 6-month follow ups from the totalstudied cases, that was 56 in the stereotactic-guided surgical
group and 102 in the medical treatment group. With such
calculations, the case numbers were different from those
reported by Zhou.5
For comparison the outcome of death or dependence,
many reports used different methods for definition of
dependence, and we used the primary outcome reported.
In some reports, where they included different data by
different definition of dependence,22,26 and if we compared
the studies using these different data, we found that the
difference became small.
Our review revealed that in terms of mortality and
dependence, minimal invasive surgery had better results
than medical treatment for all supratentorial intracerebral
hemorrhage, deep-located ICH and putaminal ICH. Crani-
otomy showed no significant better outcome than medical
treatment for all supratentorial intracerebral hemorrhage,
deep-located ICH and putaminal ICH.
Table 2 Event rate of all included randomized studies.
Total event rate EER CER OR CI p*
Mortality
Surgery vs medical (all ICH) 0.239 (865/3616) 0.21 (379/1820) 0.27 (486/1796) 0.65 0.50e0.85 0.002
Craniotomy vs medical (all ICH) 0.369 (129/350) 0.34 (55/162) 0.39 (74/188) 0.72 0.42e1.22 0.22
MIS vs medical (all ICH) 0.16 (205/1285) 0.12 (79/639) 0.20 (126/646) 0.55 0.35e0.87 0.01
Surgery vs medical (putamen ICH) 0.18 (159/883) 0.16 (69/445) 0.21 (90/438) 0.7 0.46e1.07 0.1
Craniotomy vs medical (putamen ICH) 0.508 (63/124) 0.52 (29/56) 0.5 (34/68) 0.9 0.39e2.07 0.8
MIS vs medical (putamen ICH) 0.122 (81/665) 0.09 (29/336) 0.16 (52/329) 0.52 0.31e0.86 0.01
Surgery vs medical (deep ICH) 0.166 (238/1431) 0.13 (94/704) 0.2 (144/727) 0.6 0.39e0.92 0.02
Craniotomy vs medical (deep ICH) 0.465 (80/172) 0.42 (32/77) 0.51 (48/95) 0.57 0.23e1.40 0.22
MIS vs medical (deep ICH) 0.12 (139/1154) 0.09 (50/572) 0.15 (89/582) 0.57 0.34e0.96 0.04
Mortality or dependence
Surgery vs medical (all ICH) 0.58 (2058/3548) 0.52 (928/1785) 0.64 (1130/1763) 0.62 0.46e0.84 0.002
Craniotomy vs medical (all ICH) 0.751 (757/1008) 0.73 (353/484) 0.77 (404/524) 0.83 0.41e1.67 0.6
MIS vs medical (all ICH) 0.571 (799/1400) 0.47 (324/687) 0.67 (475/713) 0.52 0.33e0.80 0.003
Surgery vs medical (putamen ICH) 0.603 (531/881) 0.53 (237/444) 0.67 (294/437) 0.7 0.37e1.32 0.27
Craniotomy vs medical (putamen ICH) 0.79 (98/124) 0.77 (43/56) 0.81 (55/68) 0.77 0.18e3.28 0.73
MIS vs medical (putamen ICH) 0.573 (380/663) 0.48 (159/335) 0.67 (221/328) 0.44 0.32e0.61 <0.001
Surgery vs medical (deep ICH) 0.643 (1270/1976) 0.57 (555/967) 0.71 (715/1009) 0.6 0.37e0.96 0.04
Craniotomy vs medical (deep ICH) 0.797 (137/172) 0.75 (58/77) 0.83 (79/95) 0.62 0.22e1.78 0.38
MIS vs medical (deep ICH) 0.53 (591/1115) 0.41 (224/551) 0.65 (367/564) 0.39 0.30e0.52 <0.001
*p  0.05 was taken as statistically significant. CERZ control event rate, the event rate of medical treatment groups; CIZ confidence
interval; EER Z experimental event rate, the event rate of surgical group; OR Z odds ratio for surgical effects about mortality and
mortality or dependence.
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